[go: up one dir, main page]

CR8785A - Profarmacos de esteroides con accion androgenica - Google Patents

Profarmacos de esteroides con accion androgenica

Info

Publication number
CR8785A
CR8785A CR8785A CR8785A CR8785A CR 8785 A CR8785 A CR 8785A CR 8785 A CR8785 A CR 8785A CR 8785 A CR8785 A CR 8785A CR 8785 A CR8785 A CR 8785A
Authority
CR
Costa Rica
Prior art keywords
steroid
propharms
androgenic action
action
androgenic
Prior art date
Application number
CR8785A
Other languages
English (en)
Inventor
Ralf Wirwa
Peter Droessher
Sven Ring
Walter Elger
Birgitt Schneider
Alexander Hillsich
Gudrun Reddersen
Original Assignee
Schering Aktiengellshaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengellshaft filed Critical Schering Aktiengellshaft
Publication of CR8785A publication Critical patent/CR8785A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invencion se refiere a profarmacos de esteroides con accion androgenica de la formula general (i), en los cuales el grupo Z esta unido con el esteroide, a composiciones farmaceuticas que contienen estos compuestos, asi como a su uso para la preparacion de medicamentos con accion androgenica.
CR8785A 2004-05-21 2006-12-05 Profarmacos de esteroides con accion androgenica CR8785A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (de) 2004-05-21 2004-05-21 Steroid-Prodrugs mit androgener Wirkung

Publications (1)

Publication Number Publication Date
CR8785A true CR8785A (es) 2007-02-05

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8785A CR8785A (es) 2004-05-21 2006-12-05 Profarmacos de esteroides con accion androgenica

Country Status (22)

Country Link
EP (1) EP1747229A1 (es)
JP (1) JP2007538026A (es)
CN (1) CN1993375A (es)
AR (1) AR049547A1 (es)
AU (1) AU2005245568A1 (es)
BR (1) BRPI0510136A (es)
CA (1) CA2564963A1 (es)
CR (1) CR8785A (es)
DE (1) DE102004025986A1 (es)
EA (1) EA200602049A1 (es)
EC (1) ECSP067028A (es)
GT (1) GT200500122A (es)
IL (1) IL179293A0 (es)
MX (1) MXPA06013469A (es)
NO (1) NO20065885L (es)
PA (1) PA8633601A1 (es)
PE (1) PE20060271A1 (es)
SV (1) SV2006002123A (es)
TW (1) TW200613317A (es)
UY (1) UY28911A1 (es)
WO (1) WO2005113575A1 (es)
ZA (1) ZA200610769B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
CN102964417A (zh) * 2012-11-30 2013-03-13 华中药业股份有限公司 17-羟基四氢吡喃醚甾族化合物的合成方法
CN107556258B (zh) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 一种4-氨基-2-氯-5(1h-四唑基-5)苯磺酰胺的制备方法
EP3533619A1 (en) * 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (de) * 1970-07-17 1973-12-15 Hoffmann La Roche Verfahren zur Herstellung von Acylderivaten
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
PA8633601A1 (es) 2006-07-03
PE20060271A1 (es) 2006-05-25
NO20065885L (no) 2006-12-19
MXPA06013469A (es) 2007-01-23
ECSP067028A (es) 2006-12-29
EP1747229A1 (de) 2007-01-31
IL179293A0 (en) 2007-03-08
ZA200610769B (en) 2008-08-27
CA2564963A1 (en) 2005-12-01
WO2005113575A1 (de) 2005-12-01
JP2007538026A (ja) 2007-12-27
DE102004025986A1 (de) 2005-12-15
GT200500122A (es) 2006-01-24
TW200613317A (en) 2006-05-01
CN1993375A (zh) 2007-07-04
SV2006002123A (es) 2006-02-15
AR049547A1 (es) 2006-08-16
BRPI0510136A (pt) 2007-10-02
UY28911A1 (es) 2005-12-30
AU2005245568A1 (en) 2005-12-01
EA200602049A1 (ru) 2007-06-29

Similar Documents

Publication Publication Date Title
ECSP099452A (es) Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
UY32648A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de enfermedades
UY31524A1 (es) Nuevos compuestos 010
CR20120283A (es) Inhibidor de bromodominio de benzodiazepina
CU20110204A7 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
UY31559A1 (es) Derivados biciclicos para usar en el tratamiento de afecciones asociadas con el receptor de androgeno - 155
SV2010003580A (es) Agonistas novedosos de los receptores de glucocorticoides
UY32426A (es) Derivados bicilicos para uso en el tratamiento de enfermedades relacionadas al receptor de androgeno
CL2008001775A1 (es) Compuestos derivados de 2-amino-7-alquinil-[1,8]naftiridona, inhibidores de vegfr-3; composición farmacéutica; combinación farmacéutica; procedimiento de preparación; compuesto intermediario; y uso en el tratamiento del cáncer.
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
CU20110185A7 (es) Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad glucocorticoide
CR8785A (es) Profarmacos de esteroides con accion androgenica
CR11479A (es) Piperazinas como agentes antiobesidad
CR11392A (es) Derivados de pirazol como inhibidores de 5-lo
UY32623A (es) Derivados bicíclicos para afecciones asociadas al receptor de andrógenos
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
CR9595A (es) Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona
GT200500311A (es) Compuestos organicos
HN2008001435A (es) Compuestos novedosos activos como antagonistas de receptores muscarinicos
GT200500121A (es) Derivados de sulfamoilbenzoato y sulfamoilaminobenzoato de estradiol.
CR9981A (es) Prodrogas de sustancias erb-selectivas, procesos para su preparacion y composiciones farmaceuticas que comprenden estos productos
BR112013001956A2 (pt) formulações
GT200500084A (es) D-homo-17-cloro-16 (17) eno esteroides.
ECSP088482A (es) Prodrogas de sustancias er-beta-selectivas, procesos para su preparación, y composiciones farmacéuticas que contienen estos compuestos
HN2009001203A (es) Derivados de ester y amida deindazolilo para el tratamiento de enfermadades mediadas por un receptor de glucocorticoides

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)